Israel: Agricultural Biotechnology Annual

  |   Attaché Report (GAIN)

As of July 2015, Israel does not have a policy that restricts the use of imported biotech commodities or derivative products. Existing regulations do not permit local commercial production of biotech crops in Israel but allows their growth for research purposes. Israeli regulations also allow biotech products to be imported, sold, and used in the production of food and pharmaceuticals in Israel. In October, 2013 new draft regulations announced by Israel's Ministry of Health called "Public Health Regulations (Food) (Novel foods) 5773 - 2013" (G/TBT/N/ISR/710) were notified to the WTO, with the US, Canada and other countries submitting comments. The draft regulation has not been approved by the Israeli Government; FAS/Tel Aviv expects that it will be approved in 2016. Once approved, the labeling regulation will come into effect one year after the publication in Israel’s Official Gazette; however, imported biotech products must be noted on the import permit once the regulation is published in the Gazette.

Israel: Agricultural Biotechnology Annual

Related Reports

Attaché Report (GAIN)

United Kingdom: Sustainable Aviation Fuel in the UK

As part of a broad push towards reducing carbon emissions in the aviation sector, the newly elected Labour government is seeking to bolster the United Kingdom’s (UK) Sustainable Aviation Fuel (SAF) industry, which builds on initiatives and policies...
On October 30, the Department for Business and Trade (DBT) extended over 220 voluntary tariff suspensions announced following the 2021 and 2023 application periods, through June 30, 2026. The announcement synchronizes multiple expiration periods...
The European Commission will allocate €132 million (approximately $138 million) towards promotion activities for EU agri-food products in 2025.